動画検索
関連広告
検索結果
Paolo Bettica, MD, PhD, Vice President of Research and Development at ITF Therapeutics, discusses the clinical trial that led to the recent ...
YouTube-CheckRare
2024/03/22Paolo Bettica, MD, PhD, Vice President of Research and Development at ITF Therapeutics, discusses Duchenne muscular dystrophy and the ...
YouTube-CheckRare
2024/03/22Yesterday, the U.S. Food and Drug Administration gave final approval of Duvyzat (givinostat), a novel histone deacetylase (HDAC) inhibitor, ...
Facebook-Muscular Dystrophy Association
2024/03/22Paolo Bettica, MD, PhD (Italfarmaco) presents at PPMD's Annual Connect Conference on June 30, 2017.
YouTube-Parent Project Muscular Dystrophy
2017/07/17Italfarmaco Provides Givinostat Update (April 22, 2020). Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy.
Parent Project Muscular Dystrophy
2020/04/27Marcello Paglione, PhD, the executive medical lead at Italfarmaco SpA, expressed his confidence in givinostat to mitigate the progression of ...
YouTube-NeurologyLive
2024/04/10Webinar: Community Update with ITF Therapeutics – Introducing DUVYZAT™ (givinostat). Parent Project Muscular Dystrophy by: Parent Project ...
Parent Project Muscular Dystrophy
2024/03/28Dr. Paolo Bettica reviews a recently completed study analysis for the Italfarmaco Phase 3 randomized controlled trial of givinostat in boys ...
YouTube-CureDuchenneMD
2022/09/20動画の見どころ1/10枚目 Update on the Development of Jiministatin
動画の見どころ2/10枚目 Mechanism of Action
動画の見どころ3/10枚目 Design of the Study
動画の見どころ4/10枚目 Result
動画の見どころ5/10枚目 Cumulative Item Failure
動画の見どころ6/10枚目 Dixon Mri
動画の見どころ7/10枚目 Apd Study
動画の見どころ8/10枚目 The Open Label Extension Study Is Continuing
動画の見どころ9/10枚目 The European Process
動画の見どころ10/10枚目 Any Plans for the Open Label Study
Parent Project Muscular Dystrophy and Italfarmaco hosted a webinar on April 26, 2017 to discuss Italfarmaco's investigational drug ...
YouTube-Parent Project Muscular Dystrophy
2017/05/01動画の見どころ1/10枚目 Disclosure and Disclaimer
動画の見どころ2/10枚目 Agenda
動画の見どころ3/10枚目 Lack of dystrophin in DMD
動画の見どころ4/10枚目 Givinostat and Muscle Regeneration
動画の見どころ5/10枚目 Anti-inflammatory Effects of Givinostat in DMD
動画の見どころ6/10枚目 Givinostat Effect in mdx Duchenne Mouse Model
動画の見どころ7/10枚目 STUDY 43: Phase 2 Trial in Ambulant DMD boys
動画の見どころ8/10枚目 Study 43: Extension Phase
動画の見どころ9/10枚目 STUDY 43: 6MWT After 3 Years of Treatment
動画の見どころ10/10枚目 Acknowledgements
On April 22, 2020, Italfarmaco joined Parent Project Muscular Dystrophy for a webinar to update the community about Italfarmaco's ...
YouTube-Parent Project Muscular Dystrophy
2020/04/27動画の見どころ1/10枚目 AGENDA
動画の見どころ2/10枚目 WHAT HAPPENS IN MUSCULAR DYSTROPHY?
動画の見どころ3/10枚目 HOW DOES GIVINOSTAT WORK?
動画の見どころ4/10枚目 PREVIOUS DATA WITH GIVINOSTAT IN DMD
動画の見どころ5/10枚目 GIVINOSTAT DMD: PHASE 3 STUDY
動画の見どころ6/10枚目 GIVINOSTAT DMD: CRITERIA
動画の見どころ7/10枚目 GIVINOSTAT DMD: STUDY PROCEDURES
動画の見どころ8/10枚目 GIVINOSTAT DMD: CLINICAL SITES in NORTH AMERICA
動画の見どころ9/10枚目 GIVINOSTAT DMD: CURRENT STATUS
動画の見どころ10/10枚目 GIVINOSTAT TRIAL UNDER COVID-19
Italfarmaco joined PPMD for a webinar on March 27, 2019 to update the community about Italfarmaco's development of Givinostat and currently ...
YouTube-Parent Project Muscular Dystrophy
2019/04/02Webinar: Community Update with ITF Therapeutics: Introducing DUVYZAT™ (givinostat) [March 2024]. 1.3K views · 2 months ago ...more. Parent ...
YouTube-Parent Project Muscular Dystrophy
2024/03/28Consideration Regarding the Study and the Results
Measuring Safety
Safety Information
Commitment to the Community
Potential Impact on Pulmonary Function
Qt Prolongation
The Most Common Side Effects That Were Seen Uh for Patients Taking Duat
Weight Limit or Weight Maximum
Questions of Cost
Increases in Strength in the Upper Limb
Givinostat in Duchenne (April 2017). Parent Project Muscular Dystrophy and Italfarmaco hosted a webinar on April 26, 2017 to discuss ...
Parent Project Muscular Dystrophy
2017/05/01Italfarmaco Provides Givinostat Update (January 2018). Italfarmaco joined PPMD for a webinar on January 24, 2018 to update the Duchenne ...
Parent Project Muscular Dystrophy
2018/01/30Italfarmaco joined PPMD for a webinar on January 24, 2018 to update the Duchenne community about Italfarmaco's development of Givinostat and ...
YouTube-Parent Project Muscular Dystrophy
2018/01/30動画の見どころ1/10枚目 Disclaimer
動画の見どころ2/10枚目 Phase 2 Study
動画の見どころ3/10枚目 Peak Expiratory Flow
動画の見どころ4/10枚目 Apd Study
動画の見どころ5/10枚目 Design of the Study
動画の見どころ6/10枚目 Data on any Increases You Might Have Seen in the Six-Minute Walk Test
動画の見どころ7/10枚目 The Time To Rise Test
動画の見どころ8/10枚目 Sibling Protocol
動画の見どころ9/10枚目 Exclusion criteria for cardiovascular disease
動画の見どころ10/10枚目 Cognitive Factors
102 likes, 6 comments - mdaorg on March 22, 2024: "Yesterday, the @FDA gave final approval of Duvyzat (givinostat), a novel histone ...
Webinar: Community Update with ITF Therapeutics: Introducing DUVYZAT™ (givinostat) [March 2024]. Parent Project Muscular Dystrophy New 341 ...
YouTube-Parent Project Muscular Dystrophy
2022/08/15In March 2024, the US FDA approved Italfarmaco's givinostat (Duvyzat) for Duchenne muscular dystrophy (DMD) patients aged six and older.
YouTube-Pharmacology Insights
2週間前Matt Trudeau, head of ITF Therapeutics, discusses givinostat, an investigational therapy for Duchenne muscular dystrophy (DMD).
YouTube-CheckRare
2024/03/18Webinar: Community Update with ITF Therapeutics – Introducing DUVYZAT™ (givinostat). 1:01:30 · Webinar: Community Update with ITF Therapeutics ...
Parent Project Muscular Dystrophy
2024/02/08